Siris Medical Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 14

Employees
  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $2.3M

  • Investors
  • 6

Siris Medical General Information

Description

Developer of radiotherapy treatment decision support system designed to inform clinicians of treatment plan outcomes in real time. The company's platform offers an artificial intelligence-based treatment decision support system for use in radiation oncology that leverages machine learning to provide decision support and trade-offs on the dose, prescription, and modality, enabling clinicians to reduce treatment-related side effects and start patient treatment sooner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
  • 1633 Bayshore Highway
  • Suite 337
  • Burlingame, CA 94010
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Siris Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A1) 01-May-2020 $2.3M 00.00 000.00 Completed Generating Revenue
3. Later Stage VC 07-Feb-2018 000 000 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 27-Jun-2014 $2M $2M 000 Completed Product Development
1. Accelerator/Incubator Completed Startup
To view Siris Medical’s complete valuation and funding history, request access »

Siris Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Siris Medical’s complete cap table history, request access »

Siris Medical Patents

Siris Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3334496-A4 Result-driven radiation therapy treatment planning Active 13-Aug-2015 0000000000 0
US-20180214714-A1 Result-driven radiation therapy treatment planning Inactive 13-Aug-2015 0000000000
CA-2995473-A1 Result-driven radiation therapy treatment planning Pending 13-Aug-2015 0000000000
EP-3334496-B1 Result-driven radiation therapy treatment planning Active 13-Aug-2015 0000000000
EP-3334496-A1 Result-driven radiation therapy treatment planning Active 13-Aug-2015 A61N5/1038
To view Siris Medical’s complete patent history, request access »

Siris Medical Executive Team (6)

Name Title Board Seat Contact Info
Colin Carpenter Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Chris Jackson Chief Financial Officer
Nicholas Mourlas Ph.D Co-Founder & Advisor
Marc Nash Chief Medical Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Siris Medical Board Members (6)

Name Representing Role Since
David Kim MD DigiTx Partners Board Member 000 0000
Gail Harris Self Board Member 000 0000
Jason Pyle Ph.D Self Chairman 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Siris Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Siris Medical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Broadway Angels Angel Group Minority 000 0000 000000 0
WVV Capital Venture Capital Minority 000 0000 000000 0
Alumni Ventures Venture Capital Minority 000 0000 000000 0
DigiTx Partners Venture Capital Minority 000 0000 000000 0
Medical Technology Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »